Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prostaglandin therapy in severe limb ischemia.

× No keyword cloud information.

32 in total

1. Fate of prostaglandins E(1) and A(1) in the human pulmonary circulation.

Authors: G L Hammond; L H Cronau; D Whittaker; C N Gillis
Journal: Surgery Date: 1977-06 Impact factor: 3.982

2. Vasodilator drugs in the treatment of peripheral arterial insufficiency.

Authors: V Hansteen; E Lorentsen
Journal: Acta Med Scand Suppl Date: 1974

3. Femoral-artery infusion of prostaglandin E 1 in severe peripheral vascular disease.

Authors: L A Carlson; I Eriksson
Journal: Lancet Date: 1973-01-20 Impact factor: 79.321

4. Plasma exchange in Raynaud's phenomenon.

Authors: W A Hamilton; J M White; L T Cotton
Journal: Lancet Date: 1980-08-30 Impact factor: 79.321

5. Healing of ischaemic ulcers by intravenous prostaglandin E1 in a woman with thrombangitis obliterans.

Authors: A G Olsson; N Thyresson
Journal: Acta Derm Venereol Date: 1978 Impact factor: 4.437

6. Intravenous prostaglandin E1 in severe peripheral vascular disease.

Authors: L A Carlson; A G Olsson
Journal: Lancet Date: 1976-10-09 Impact factor: 79.321

7. A multi-clinical double blind study with PGE, (alpha-cyclodextrin clathrate) in patients with ischemic ulcer of the extremities.

Authors: S Sakaguchi; A Kusaba; Y Mishima; K Kamiya; A Nishimura; K Furukawa; S Shionoya; M Kawashima; T Katsumura; A Sakuma
Journal: Vasa Date: 1978 Impact factor: 1.961

8. A new criterion for predicting response to lumbar sympathectomy in patients with severe arteriosclerotic occlusive disease.

Authors: F R Plecha; R A Bomberger; M Hoffman; K Mac Pherson
Journal: Surgery Date: 1980-09 Impact factor: 3.982

9. Amputation for vascular disease: the experience of a peripheral vascular unit.

Authors: D R Finch; M Macdougal; D J Tibbs; P J Morris
Journal: Br J Surg Date: 1980-04 Impact factor: 6.939

10. Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.

Authors: H Pickles; J O'Grady
Journal: Br J Clin Pharmacol Date: 1982-08 Impact factor: 4.335

1 in total

1. Clinical studies on the vasodilating and anti-platelet effects of OP-41483, a prostacyclin derivative.

Authors: A Kusaba; H Shiroma; D R Shrestha; K Koja; M Kina; Y Kuniyoshi; K Iha; O Kinjo; M Akasaki; T Kugai
Journal: Jpn J Surg Date: 1991-01

1 in total